Related Experiment Video
Updated: Apr 11, 2026
07:56
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
23.5K
Flowing through the CRISPR-CAScade: Will genome editing boost cell therapies?
1Stem Cell Unit, Department of Genetics, Silberman Institute of Life Sciences, The Hebrew University, Jerusalem, 91904 Israel.
Molecular and Cellular Therapies
|June 10, 2015
Summary
Groundbreaking genome editing technologies and stem cell advancements are revolutionizing regenerative medicine. Genetically engineered stem cells hold promise for future clinical therapies.
Area of Science:
- Biotechnology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Recent progress in genome editing enables precise DNA targeting.
- Advances in induced pluripotent stem cells (iPSCs) bring cell therapies closer to clinical application.
Purpose of the Study:
- To envision the impact of genome editing on stem cell research.
- To explore the potential of genetically engineered cells in regenerative medicine.
Main Methods:
- This commentary synthesizes current advancements in genome editing and stem cell biology.
- It projects future applications based on these technologies.
Main Results:
- Genome editing tools can enhance the precision and efficiency of stem cell modification.
- Genetically engineered stem cells offer new therapeutic possibilities.
Conclusions:
- The convergence of genome editing and stem cell research is poised to accelerate regenerative medicine.
- Future therapies may involve the clinical use of precisely engineered stem cells.
Related Concept Videos
01:28CRISPR/Cas9 Genome Editing
3.1K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.1K
01:59CRISPR
60.0K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
60.0K
01:59CRISPR
19.0K
19.0K
02:53CRISPR and crRNAs
20.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
20.3K
02:31Homologous Recombination
65.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.8K